Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Cd8-Positive Lymphocyte Infiltration As a Marker of Anti-Tumor Immune Response in Rectal Cancer: Pre- and Post-Neoadjuvant Radiotherapy Comparison Publisher



S Salarvand SAMANEH ; R Abyaneh ROMINA ; A Raee ABDORREZA ; M Yaghootikhorasani MAHDIYEH ; F Mohammadjani FARIBA ; F Nili FATEMEH ; M Aghili MAHDI ; R Ghalehtaki REZA
Authors

Source: Clinical and Translational Radiation Oncology Published:2025


Abstract

Background: Antitumor immunity, exerted by CD8+ cytotoxic T lymphocytes, plays a vital role in tumor control. Therefore, the present study was conducted to compare the amount of CD8+ tumor-infiltrating lymphocytes (TILs) before and after either long- (LCRT) or short-course radiotherapy (SCRT) in rectal cancer. Methods: This study retrospectively assessed rectal cancer patients treated by neoadjuvant radiotherapy between 2019 and 2021. Biopsy and surgical samples were subjected to immunohistochemical staining to count CD8+ TILs. The association between the post-to-pre-treatment CD8+ count ratio and treatment groups, histopathological factors, and response to treatment was assessed. Results: A total of 34 patients were included, with 23 (67.6 %) receiving LCRT and 11 (32.4 %) receiving SCRT. The mean age was 58.56 ± 13.59 years. The number and percentage of CD8+ TILs increased significantly after radiotherapy in all patients (P < 0.001). An increase in CD8+ TILs was observed in both groups, with LCRT showing a median post-to-pre-treatment count ratio of 2.77 and SCRT showing 3.1 (P = 0.127). A generalized linear multivariate model adjusting for mucinous histology, surgical grade, and pathological stages revealed that SCRT was associated with a significantly higher post-to-pre-treatment CD8+ count ratio compared to LCRT (P = 0.03). Conclusion: Our study highlights that both SCRT and LCRT significantly increase CD8+ TIL count and percentage, reflecting robust immune activation after radiotherapy in rectal cancer, with SCRT showing a higher relative increase, though not statistically significant in unadjusted analyses. After adjusting for histopathological variables, SCRT was independently associated with a greater increase in CD8+ T cells. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Outcomes of Neoadjuvant Chemoradiotherapy in T4 Rectal Cancer Patients: A Real-World Single Institution Experience, Radiation Oncology Journal (2024)
2. High Dose Brachytherapy Boost After Chemoradiation in Rectal Cancer Patients: A Retrospective Study, International Journal of Cancer Management (2022)
3. How Accurate Is Mri to Predict Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer?, Tehran University Medical Journal (2016)
Experts (# of related papers)
View all Related Experts
Mahdi Aghili (6)
Farshid Farhan (5)
Other Related Docs
4. Evaluation of the Histopathologic Status of Rectal Adenocarcinoma and Its Regional Lymph Nodes After Neoadjuvant Therapy, and Its Relation to the Duration of Disease-Free Survival, Indian Journal of Pathology and Microbiology (2022)
5. Short-Course Versus Long-Course Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: Long-Term Results of a Randomized Controlled Trial, International Journal of Colorectal Disease (2025)
6. Current Approaches in Intensification of Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: A Review, Radiation Oncology Journal (2021)
7. Evaluating the Impact of Adjuvant Chemotherapy on Survival Outcomes in Stage Ii Rectal Cancer: A Retrospective Cohort Study, Updates in Surgery (2025)
8. Advances in Therapeutic Targeting of Immune Checkpoints Receptors Within the Cd96-Tigit Axis: Clinical Implications and Future Perspectives, Expert Review of Clinical Immunology (2022)
9. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
10. Decline in Peripheral Blood Nkg2d+Cd3+Cd56+ Nkt Cells in Metastatic Colorectal Cancer Patients, Bratislava Medical Journal (2018)
11. Cd31 Positivity and Prediction of Tumor Invasive Behavior in Colorectal Cancer, International Journal of Cancer Management (2023)
12. Evaluation of the Types and Frequency of Unstable Chromosomal Aberrations Induced in Lymphocytes of Breast Cancer Patients Before and After Radiotherapy, International Journal of Radiation Research (2022)
13. Preoperative Carcinoembryonic Antigen As a Predictor of 5-Year Survival in Rectal Cancer: Proposing a New Prognostic Cutoff, Journal of Gastrointestinal Cancer (2025)
14. Radiation Dose and Schedule Influence the Abscopal Effect in a Bilateral Murine Ct26 Tumor Model, International Immunopharmacology (2022)
15. Abscopal Effect in Radioimmunotherapy, International Immunopharmacology (2020)
16. Neoadjuvant Chemoradiotherapy With or Without Pd-1/Pd-L1 Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis, BMC Cancer (2025)
17. Tumor-Infiltrating Cd8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma, Indian Journal of Dermatology (2015)
18. Analysis of Patients With Locally Advanced Rectal Cancer Given Neoadjuvant Radiochemotherapy With or Without Rt Dose Intensification: A Multicenter Retrospective Study – Atlantis Part I, Radiotherapy and Oncology (2025)
19. Predictive Value of Flexible Proctosigmoidoscopy and Laboratory Findings for Complete Clinical Responses After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Primary Rectal Cancer: A Retrospective Cohort Study, International Journal of Colorectal Disease (2024)
20. Addition of Oxaliplatin to Neoadjuvant Radiochemotherapy in Mri-Defined T3, T4 or N+ Rectal Cancer: A Randomized Clinical Trial, Asia-Pacific Journal of Clinical Oncology (2017)